Obesity is a risk factor for type 2 diabetes mellitus (T2DM), and some evidence from animal studies suggests that treatment with GDF-15 decreases body weight and glucose levels, primarily due to the loss of fat mass and reduced food intake [17]. Here, GDF15 is linked to type 2 diabetes mellitus.